References
- Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425–32.
- Casabiell X, Pineiro V, Peino R et al. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 1998; 83: 2149–55.
- Gettys TW, Harkness PJ, Watson PM. The β3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 1996; 137: 4054–7.
- Licinio J, Negrao AB, Mantzoros C et al. Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinol Metab 1998; 83: 4140–7.
- Vettor R, De Pergola G, Pagano C et al. Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest 1997; 27: 1016–24.
- Luukkaa V, Pesonen U, Huhtaniemi I et al. Inverse correlation between serum testosterone and leptin in men. J Clin Endocrinol Metab 1998; 83: 3243–6.
- Deng C, Moinat M, Curtis L et al. Effects of β-adrenoceptor subtype stimulation on obese gene messenger ribonucleic acid and on leptin secretion in mouse brown adipocytes differentiated in culture. Endocrinology 1997; 138: 548–52.
- Fain JN, Bahouth SW. Hormonal regulation of 18S RNA, leptin mRNA, adipocytes from hypothyroid rats. Metabolism: Clin Experiment 1998; 47: 1455–61.
- Fritsche A, Wahl HG, Metzinger E et al. Evidence for inhibition of leptin secretion by catecholamines in man. Exp Clin Endocrinol Diabetes 1998; 106: 415–8.
- Donahoo WT, Jensen DR, Yost TJ, Eckel RH. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 1997; 82: 4139–43.
- Kosaki A, Yamada K, Kuzuya H. Reduced expression of the leptin gene (ob) by catecholamine through a G(S) proteincoupled pathway in 3T3-L1 adipocytes. Diabetes 1996; 45: 1744–9.
- Sakane N, Yoshida T, Mizutani T, Nakagawa Y. Serum leptin levels in a patient with pheochromocytoma. J Clin Endocrinol Metab 1998; 83:1400.
- Böttner A, Eisenhofer G, Torpy DJ et al. Lack of leptin suppression in response to hypersecretion of catecholamines in pheochromocytoma patients. Metabolism 1999; 48: 543–5.
- Januszewicz W, Wocial B. Pheochromocytoma – the catecholamine-dependent hypertension. J Physiol Pharmacol 1995; 46: 285–93.
- Jockers R, Isaad T, Zilberfarb V, Coppet P., Marullo S, Strosberg D. Desensitization of the β-adrenergic response in human brown adipocytes. Endocrinology 1998; 139: 2676–84.
- Giacobino J-P. Role of the β3-adrenoceptor in the control of leptin expression. Horm Metab Res 1996; 28: 633–7.
- Banks WA. Enhanced leptin transport across the blood-brain barrier by α1-adrenergic agents. Brain Res 2001; 899: 209–17.